DUBLIN--(BUSINESS WIRE)--Jan 14, 2021--
The Global Glycobiology Market was valued at USD 938.76 Million and is expected to grow at a doubled digit CAGR of 13.83% during the forecast period.
The Global Glycobiology Market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of the market during the forecast period.
Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of the market over the next few years. Furthermore, increasing research activities in glycomics, technological advancements and rising government initiatives is also among the major drivers for the Global Glycobiology Market.
The Global Glycobiology Market is segmented based on product, application, End-user, company, and region. Based on product, the market can be categorized into enzymes, instruments, reagents, and kits. Among the following, enzymes contribute the majority of share in the market nearly about 35%.
Based on enzymes, they can be further bifurcated into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is leading the market is expected to dominate the market during the forecast period as well. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.
Based on instruments, the market is fragmented into HPLC, mass spectrometry, MALDI-TOF, antibody arrays, lectin arrays, and others. The HPLC segment is attributed to dominate the market in the coming years. Based on reagents, the market is segmented into glycoproteins, oligosaccharides, monosaccharides, and others.
Based on kits, the glycobiology market is sub-segmented into glycan releasing kit, glycan purification kit, glycan labeling kit, and others.
Years considered for this report:
- Historical Years: 2015-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Period: 2021-2025
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Glycobiology Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. By Application
5.3. Factors driving the Glycobiology Market
6. Global Glycobiology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Enzymes, Instruments, Reagents and Kits)
184.108.40.206. By Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
220.127.116.11. By Instruments (HPLC, Antibody arrays, Lectin arrays, MALDI-TOF, Mass spectroscopy, Others)
18.104.22.168. By Reagents (Monosaccharides, Glycoproteins, Oligosaccharides, Others)
22.214.171.124. By Kits (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
6.2.2. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
6.2.3. By End-user (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map
7. North America Glycobiology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.3. By End-user
7.2.4. By Country
7.3. North America: Country Analysis
8. Europe Glycobiology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.3. By End-user
8.2.4. By Country
8.3. Europe: Country Analysis
9. Asia Pacific Glycobiology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.3. Market Share & Forecast
9.3.1. By Product
9.3.3. By End-user
9.3.4. By Country
9.4. Asia Pacific: Country Analysis
10. South America Glycobiology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.3. By End-user
10.2.4. By Country
10.3. South America: Country Analysis
11. Middle East and Africa Glycobiology Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type of Enzyme
11.2.2. By Type of Kit
11.2.3. By Application
11.2.4. By End-user
11.2.5. By Country
11.3. MEA: Country Analysis
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
14.1. Merck & Co., Inc.
14.2. Agilent Technologies, Inc.
14.3. Thermo Fisher Scientific
14.4. New England Biolabs, Inc.
14.5. Shimadzu Corporation
14.6. Takara Bio Inc.
14.7. Waters Corporation
14.8. Asparia Glycomics S.L.
14.9. Bruker Corporation
14.10. RayBiotech, Inc.
14.11. Z Biotech, LLC.
14.12. Chemily Glycoscience
14.13. Dextra Laboratories Ltd.
14.14. Lectenz Bio
14.15. Ludger Ltd
14.16. R&D Systems, Inc.
14.17. Glycotope GmbH
14.18. Danaher Corporation
14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
14.20. Bio-Rad Laboratories
15. Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/efwaso
View source version on businesswire.com:https://www.businesswire.com/news/home/20210114005443/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/14/2021 05:09 AM/DISC: 01/14/2021 05:10 AM